1. Home
  2. LMAT vs RXRX Comparison

LMAT vs RXRX Comparison

Compare LMAT & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$80.46

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Recursion Pharmaceuticals Inc.

RXRX

Recursion Pharmaceuticals Inc.

HOLD

Current Price

$3.85

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMAT
RXRX
Founded
1983
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
LMAT
RXRX
Price
$80.46
$3.85
Analyst Decision
Buy
Buy
Analyst Count
5
4
Target Price
★ $105.80
$7.50
AVG Volume (30 Days)
205.7K
★ 17.2M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
★ 0.93%
N/A
EPS Growth
★ 30.57
14.79
EPS
★ 1.42
N/A
Revenue
★ $249,602,000.00
$74,681,000.00
Revenue This Year
$14.21
$12.11
Revenue Next Year
$8.88
$82.52
P/E Ratio
$56.92
★ N/A
Revenue Growth
13.53
★ 26.92
52 Week Low
$78.22
$2.77
52 Week High
$118.01
$7.18

Technical Indicators

Market Signals
Indicator
LMAT
RXRX
Relative Strength Index (RSI) 45.46 54.64
Support Level $78.65 $2.90
Resistance Level $82.45 $4.03
Average True Range (ATR) 1.50 0.22
MACD 0.55 0.04
Stochastic Oscillator 70.00 52.83

Price Performance

Historical Comparison
LMAT
RXRX

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

Share on Social Networks: